CA3085118A1 - Blood testing system and method - Google Patents

Abstract

Embodiments of a blood testing system are described where in embodiments, is an automated thromboelastometry system useful at a point-of-care site. Methods involving use and components of the system are embodied. Namely, a method of controlling accuracy of a thromboelastometry analysis system, comprising: detecting, at a vibration sensor, an amount of vibration; receiving, at one or more processors, vibration data indicating the amount of vibration detected; comparing, at the one or more processors, the received vibration data to a threshold limit value; and generating, at the one or more processors, a vibration-related error when the received vibration data is greater than the threshold limit value based on the comparison of the received vibration data to the threshold limit value.

Description

Description of Fee (standard fee) 1. Application Fee (1 x $400.00): $400.00

2. Registration of a document (3 x $100.00): $300.00

3. Examination of an application (1 x $800.00): $800.00

4. Application Maintenance Fee - 2nd anniversary (1 x $100.00): $100.00

5. Application Maintenance Fee - 3rd anniversary (1 x $100.00): $100.00

6. Application Maintenance Fee - 4th anniversary (1 x $100.00): $100.00 Total Fee Payment: $1,800.00 Bartoszewicz, Lola A
Aird & McBurney LP
181 Bay Street, Suite 1800 Brookfield Place Toronto Ontario Canada Tel: 4168654708 Fax: 416 863-1515 Email:patentmail@airdmcburney.com Transmission Identifier: pgc_DrLBartoszewicz_20200630083025112_8419357 Date Recue/Date Received 2020-06-30 file:///ecprint-proclic.gc.ca/...t/inbasket/ToBeStamped/pgc_DrLBartoszewicz_20200630083025112_4 688490564490007261_8419357.html[2020-07-02 8:10:37 AM]

AIRED McBURNEY I
Lola A. Bartoszewicz, Ph.D.
Direct: 416-865-4708 E-mail: lbadoszewicz airdmcburney.com June 30, 2020 Our Ref: 14405-5021 (157774) LAB
The Commissioner of Patents Canadian Intellectual Property Office Place du Portage I
50 Victoria Street, Room C-114 Gatineau, Quebec K1A 0C9 Dear Commissioner:
This is a divisional application for patent in the name of CA CASYSO GMBH, entitled BLOOD
TESTING SYSTEM AND METHOD. This application is a divisional of Canadian Patent Application No. 2990573, filed on June 28, 2016.
Enclosed are the following:
= Description = Claims = Abstract = Drawings = Petition, including:
= Statement of Entitlement:
[ X ] Enclosed = Claim to Convention Priority = Appointment of Patent Agent and Representative in Canada = Certified Copy of foreign previously regularly filed applications:
[ X ] Filed in Parent Application during International Stage = Examination of this application is requested = Fee Payment done online.
We request that the ownership documentation registered/recorded in Canadian Patent Application No. 2990573,under registration numbers 05740191; 05740192; and be registered/recorded against this divisional application.
We further request that any references made of record in Canadian Patent Application No. 2990573, be made of record for this divisional application.
Send correspondence for this matter by email to patentmailRairdmcburnev.com.
Aird & McBurney LP Brookfield Place, 181 Bay Street, Suite 1800, Toronto, Canada M5J 2T9 416.863.1500 H 416.863.1516 airdmcburney.com Date Recue/Date Received 2020-06-30 June 30, 2020 Please charge the AIRD & MCBURNEY LP credit card for the total amount indicated below.
Application Fee: $400.00 Registration/Recordal Fees: $300.00 Examination Fee: $800.00 Maintenance Fees due June 28, 2018 to June 28, 2020: $300.00 Total Amount: $1800.00 Should the fees submitted with this letter be insufficient to cover all of the fees for which payment is explicitly or implicitly requested by this letter, please charge the AIRD & MCBURNEY
LP credit card for the amount of the insufficiency. In the event the AIRD &
MCBURNEY LP credit card is unable to be charged for the fees and/or any insufficiency, please deduct the fees and/or any insufficiency from the AIRD & MCBURNEY LP Deposit Account No. 600002626.
Respectfully submitted, AAA{
AIRD & MCBURNEY LP
Patent & Trade-Mark Agents LAB/mid Ends.
AIRD McBUkNEY
Date Recue/Date Received 2020-06-30 CANADA
AIRD McBURNEY I PATENT APPLICATION
Our Ref: 14405-5021 (157774) LAB
PETITION FOR GRANT OF A PATENT
1. The Applicant, CA CASYSO GMBH, whose complete address is Sankt Jakobs-Strasse 17, CH-4052 Basel, Switzerland, requests the grant of a patent in Canada for an invention entitled BLOOD TESTING SYSTEM AND METHOD, which is described and claimed in the accompanying specification and drawings.
2. This application is a divisional application of Canadian Patent Application No.
2990573, filed in Canada on June 28, 2016.
3. The inventors are:
(a) BELS, Kevin, of Zur Deutschen Einheit 10, 81929 Munich, Germany;
(b) BRANTL, Christian, of Fehwiesenstrasse 8, 81673 Munich, Germany; and (c) WITTMANN, Johannes, of Leonhardiweg 11, 81829 Munich, Germany.
4. The Applicant is entitled to apply for the patent.
5. The Applicant requests priority in respect of the application on the basis of the following previously regularly filed applications:
Country of Filing Application No. Filing Date US 14/754300 June 29, 2015 EP 15174565.0 June 30, 2015 JP 2015-132034 June 30, 2015 6. The Applicant appoints AIRD & MCBURNEY LP, whose complete address in Canada is Brookfield Place, 181 Bay Street, Suite 1800, Box 754, Toronto, ON M5J 2T9, Telephone (416) 865-4702, Fax No. (416) 863-1515, as the Applicant's patent agent and representative in Canada.
Date Recue/Date Received 2020-06-30

7. The Applicant requests that Figure No. 1 of the drawings accompanies the Abstract when the application is open to public inspection under Section 10 of the Patent Act or published.
G---AIRD & MCBURNEY LP
Patent & Trade-Mark Agents LAB/mid Date Recue/Date Received 2020-06-30 Blood Testing System and Method TECHNICAL FIELD
This document relates to systems and methods for testing characteristics of a blood sample, such as an automated thromboelastometry system for point-of-care whole blood coagulation analysis.
BACKGROUND
Hemostasis is the human body's response to blood vessel injury and bleeding.
Hemostasis involves a coordinated effort between platelets and numerous blood clotting proteins (or clotting factors), resulting in the formation of a blood clot and the subsequent stoppage of bleeding.
Various methods have been introduced to assess the potential of blood to form an adequate clot and to determine the blood clot's stability. Common laboratory tests such as thrombocyte counts or the determination of fibrin concentration provide information on whether the tested component is available in sufficient amount, but some of those tests might not determine whether the tested component works properly under physiological conditions.
Other laboratory tests work on blood plasma, which may impose additional preparation steps and additional time beyond what is preferred, for example, in the point-of-care context (e.g., in a surgical theater during a surgical operation).
Another group of tests to assess the potential of blood to form an adequate clot is known as "viscoelastic methods." In at least some viscoelastic methods, the blood clot firmness (or other parameters dependent thereon) is determined over a period of time, for example, from the formation of the first fibrin fibers until the dissolution of the blood clot by fibrinolysis. Blood clot firmness is a functional parameter which contributes to hemostasis in vivo, as a clot must resist blood pressure and shear stress Date Recue/Date Received 2020-06-30

8 at the site of vascular injury or incision. In many cases, clot firmness may result from multiple interlinked processes including coagulation activation, thrombin formation, fibrin formation and polymerization, platelet activation, and fibrin-platelet interaction.
To isolate and test particular functions of thrombocytes, fibrinogen, and other factors in a blood sample, reagent compounds can be mixed with the blood sample to activate or inhibit certain components in the blood sample.
SUMMARY
Some embodiments of a system for testing characteristics of a blood sample (which, as used herein, should be understood to include blood or derivatives of blood such as plasma) include a control console configured for testing a blood sample to provide a point-of-care whole blood coagulation analysis. For example, the system can serve as an automated thromboelastometry system for providing detailed and prompt results of blood coagulation characteristics in response to receiving one or more samples of blood that have been mixed with various types of reagents.
In some embodiments, the thromboelastometry system includes a reusable analyzer console and one or more single-use components configured to mate with the console. In one example, to operate the thromboelastometry system, a user is prompted by a user interface of the analyzer console to initiate a number of blood and reagent transfer and mixing operations. Thereafter, the analyzer console automatically performs (without requiring further user interaction with the analyzer console or the blood sample) the testing and displays the results on a graphical display using qualitative graphical representations and quantitative parameters. Such assays provide information on the whole kinetics of hemostasis, such as clotting time, clot formation, clot stability, and lysis; moreover, such information can be promptly output from a user interface of the system to provide reliable and prompt results indicative of a patient's blood characteristics at the point-of-care (e.g., while the patient is in a surgical room undergoing surgery).
In one implementation, a control console for measuring coagulation characteristics of a blood sample includes: (i) a control unit housing, (ii) a user interface coupled to the control unit housing for displaying coagulation characteristics of a blood sample, and (iii) a plurality of individual thromboelastometry measurement modules housed in the control unit housing. Each measurement module of the plurality of individual thromboelastometry measurement modules includes a shaft Date Recue/Date Received 2020-06-30 configured to receive a probe for testing the blood sample using a probe and cup arrangement. Each individual measurement module of the plurality of individual thromboelastometry measurement modules includes a dedicated actuation unit that drives rotation of a respective shaft of the individual measurement module independently from rotation of shafts of all other individual measurement modules of the plurality of individual thromboelastometry measurement modules.
Such a control console for measuring coagulation characteristics of a blood sample may optionally include one or more of the following features. In some embodiments, the actuation unit comprises a stepper motor. The stepper motor may optionally include a threaded driveshaft. In various embodiments, the actuation unit also includes a slider unit. The slider unit may have a threaded collar that is threadably engaged with the threaded drive shaft of the motor such that the motor can drive the slider unit to translate linearly. In particular embodiments, the actuation unit also includes a spring wire. In some such embodiments, a linear translation of the slider unit may cause a pivoting of the shaft because of the spring wire extending between the slider unit and the shaft.
In various embodiments of the control console for measuring coagulation characteristics of a blood sample, the actuation unit further comprises a magnet that attracts the spring wire to the slider unit. The spring wire may be magnetically attracted to a curved surface of the slider unit. Optionally, the actuation unit may include a sensor that is configured to detect a position of the slider unit.
In some embodiments, the sensor includes a Hall effect sensor. In various embodiments, the actuation unit may include one or more end-of-travel sensors that are configured to detect travel limits of the slider unit. The control console may also include one or more vibration sensors housed in the control unit housing. In some embodiments, each individual measurement module of the plurality of individual thromboelastometry measurement modules includes one or more vibration sensors.
In particular embodiments of the control console for measuring coagulation characteristics of a blood sample, each individual measurement module of the plurality of individual thromboelastometry measurement modules includes an evaluation unit for evaluating a charge-coupled device (CCD) component. In some embodiments, the evaluation unit may be configured to: (i) receive brightness distribution data from the CCD, (ii) generate CCD calibration data based on the Date Recue/Date Received 2020-06-30 brightness distribution data, and (iii) compare the CCD calibration data to real-time-measured CCD brightness distribution data. In some embodiments, each individual measurement module of the plurality of individual thromboelastometry measurement modules may further include a heater configured to heat a cup of the probe and cup arrangement.
In another implementation, a method for evaluating a CCD component of a thromboelastometry analysis system is performed by one or more processors of the thromboelastometry analysis system, or by one or more processors of an individual AD-module. The method includes receiving brightness distribution data from the CCD, generating CCD calibration data (wherein the CCD calibration data is generated based on the brightness distribution data from the CCD), and comparing (while the thromboelastometry analysis system is performing a thromboelastometry analysis) the CCD calibration data to real-time-measured CCD brightness distribution data.
In some embodiments, the brightness distribution data from the CCD represents individual brightness data from a plurality of individual pixels of the CCD.
Such a method for evaluating a CCD component of a thromboelastometry analysis system performed by one or more processors of the thromboelastometry analysis system or one or more processors of an individual AD-module may optionally include one or more of the follow features. In some embodiments, the method further includes determining, a position of a falling or rising edge of the brightness distribution data from the CCD.
In another implementation, a method of controlling accuracy of a thromboelastometry analysis system is performed by one or more processors of the thromboelastometry analysis system, or by one or more processors of an individual AD-module. The method includes receiving vibration data indicative of a detected level of vibration of the thromboelastometry analysis system, comparing the received vibration data to a threshold limit value, and generating a vibration error indication in response to the received vibration data being greater than the threshold limit value.
Such a method of controlling accuracy of a thromboelastometry analysis system may optionally include one or more of the following features. In some embodiments, the method also includes receiving, at one or more processors of the thromboelastometry analysis system, positional indication data indicative of a detected position of a slider unit in relation to an actuation unit of the Date Recue/Date Received 2020-06-30 thromboelastometry analysis system. In particular embodiments, the method also includes comparing, by the one or more processors of the thromboelastometry analysis system, the received positional indication data to one or more threshold limit values. In various embodiments, the method also includes generating, by the one or more processors of the thromboelastometry analysis system and based on the comparison of the received positional indication data to the one or more threshold limit values, a position error indication in response to the received positional indication data being greater than the one or more threshold limit values.
In another implementations, a method of controlling accuracy of a thromboelastometry analysis system is performed by one or more processors of the thromboelastometry analysis system, or by one or more processors of an individual AD-module. The method includes receiving positional indication data indicative of a detected position of a slider unit in relation to a actuation unit of the thromboelastometry analysis system, comparing the received positional indication data to one or more threshold limit values, and generating (based on the comparison of the received positional indication data to the one or more threshold limit values) a position error indication in response to the received positional indication data being greater than the one or more threshold limit values.
Such a method of controlling accuracy of a thromboelastometry analysis system may optionally include one or more of the following features. In some embodiments, the positional indication data includes one or more signals from one or more end-of-travel sensors that indicate whether the slider unit is positioned at a targeted travel limit position. In particular embodiments, the positional indication data includes one or more signals from one or more sensors that indicate a real-time position of the slider unit as the slider unit linearly translates back and forth along a linear path.
Some or all of the embodiments described herein may provide one or more of the following advantages. First, some embodiments of a thromboelastometry system described herein are configured with independent actuation units for individual modules or channels of multiple testing and measurement channels. For example, in some embodiments the thromboelastometry system includes four modules or channels, each of which has an independent actuation unit. Accordingly, the actuation of each testing and measurement module can be controlled independently of the other Date Recue/Date Received 2020-06-30 testing and measurement module. In addition, the use of independent actuation units for each module of multiple testing and measurement modules provides a modular design that affords advantages for the performance of maintenance on the system in some scenarios.
Second, the actuation units of some embodiments of the thromboelastometry system are driven using a rotary actuator that is positionally controllable (e.g., a stepper motor coupled to a programmable stepper motor control system, or another type of suitable rotary actuator with encoder feedback coupled to a control system).
The use of positionally controllable actuators (e.g,, motors) advantageously allows for programmable actuation patterns. In addition, in some embodiments stepper motors allow for greater precision of rotary thromboelastometry system actuation, as compared to some other types of motors. Further, in some embodiments the stepper motors provide enhanced isolation from some external error influences, such as vibration.
Third, some embodiments of the thromboelastometry system are configured with firmware for self-evaluation and calibration of the CCD (charge-coupled device) portion of the thromboelastometry detection system. Accordingly, measurement inaccuracies can be reduced or eliminated in some cases. In some such embodiments, the functionality of each individual pixel of the CCD is verified prior to operation of thromboelastometry tests. In result, the consistency of the performance of the thromboelastometry system is enhanced.
Fourth, some embodiments of the thromboelastometry system are configured with additional firmware for supervising and evaluating functional aspects of the rotary thromboelastometry actuation and detection systems. For example, in some embodiments vibrations that might distort the measurement signals are detected and used to manage the thromboelastometry system. Further, in some embodiments sensors are included that detect the movement and end-of-travel positions of the rotary thromboelastometry actuation systems. These systems for supervising and evaluating functional aspects of the rotary thromboelastometry actuation and detection systems provide a robust measurement system and facilitate enhanced measurement quality (e.g., enhanced accuracy and/or precision of the thromboelastometry measurements).

Date Recue/Date Received 2020-06-30 In accordance with an aspect of the invention is a method for evaluating a charge-coupled device (CCD) component of a thromboelastometry analysis system, the method comprising:
receiving, at one or more processors of the thromboelastometry analysis system, brightness distribution data from the CCD, wherein the brightness distribution data from the CCD represents individual brightness data from a plurality of individual pixels of the CCD;
generating, by the one or more processors of the thromboelastometry analysis system, CCD
calibration data, wherein the CCD calibration data is generated based on the brightness distribution data from the CCD; and comparing, by the one or more processors of the thromboelastometry analysis system and while the thromboelastometry analysis system is performing a thromboelastometry analysis, the CCD calibration data to real-time-measured CCD brightness distribution data.
In accordance with a further aspect is a method of controlling accuracy of a thromboelastometry analysis system, the method comprising:
receiving, at one or more processors of the thromboelastometry analysis system, vibration data indicative of a detected level of vibration of the thromboelastometry analysis system;
comparing, by the one or more processors of the thromboelastometry analysis system, the received vibration data to a threshold limit value; and generating, by the one or more processors of the thromboelastometry analysis system and based on the comparison of the received vibration data to the threshold limit value, a vibration error indication in response to the received vibration data being greater than the threshold limit value.
According to a further aspect is a method of controlling accuracy of a thromboelastometry analysis system, the method comprising:
receiving, at one or more processors of the thromboelastometry analysis system, positional indication data indicative of a detected position of a slider unit in relation to a actuation unit of the thromboelastometry analysis system;
comparing, by the one or more processors of the thromboelastometry analysis system, the received positional indication data to one or more threshold limit values; and generating, by the one or more processors of the thromboelastometry analysis system and based on the comparison of the received positional indication data to the one or more threshold limit values, a position error indication in response to the received positional indication data being greater than the one or more threshold limit values.
6a Date Recue/Date Received 2020-06-30 The details of one or more embodiments of the invention are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of the invention will be apparent from the description and drawings.
DESCRIPTION OF DRAWINGS
FIG. 1 is a perspective view of an example thromboelastometry system, in accordance with some embodiments.
FIG. 2 is an example of a graphic that quantifies the firmness of a blood clot during clot formation, as calculated and displayed by the thromboelastometry system of FIG. 1.
FIG. 3 is a schematic diagram depicting an example rotary thromboelastometry detection system portion of the thromboelastometry system of FIG. 1.
FIG. 4 is a perspective view of an example actuation and detection module (also referred to herein as an "AD-module" or "ADM") for an individual thromboelastometry measurement channel of the thromboelastometry system of FIG. 1.
FIG. 5 is a perspective exploded view of the example AD-module of FIG. 4.
FIG. 6 is a perspective exploded view of an actuation unit of the example AD-module of FIG. 4.
FIG. 7 is a perspective exploded view of a slider portion of the actuation unit of .. FIG. 6.
FIG. 8 is a flowchart of an example CCD evaluation process that can be used in conjunction with the thromboelastometry system of FIG. 1.
FIG. 9 is a flowchart of another CCD evaluation process that can be used in conjunction with the thromboelastometry system of FIG. 1.
FIG. 10 is a flowchart of a thromboelastometry measurement quality control process that can be used in conjunction with the thromboelastometry system of FIG. 1.
FIG. 11 is a flowchart of another thromboelastometry measurement quality control process that can be used in conjunction with the thromboelastometry system of FIG. 1.
Like reference symbols in the various drawings indicate like elements.

Date Recue/Date Received 2020-06-30 DETAILED DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS
Referring to FIG. 1, some embodiments of an example blood testing system 100 include a blood analyzer console 110 along with a graphical user interface that is coupled with the analyzer console 110. In the depicted embodiment, the blood testing system 100 is a thromboelastometry system that is configured to determine a number of blood coagulation characteristics of a blood sample. One example of such a thromboelastometry system 100 is the ROTEM delta Thromboelastometry system available from Tem International GmbH headquartered in Munich, Germany.
Thromboelastometry and thromboelastography are based on the measurement of the elasticity of blood by continuous graphic logging of the firmness of a blood clot during clot formation (e.g., pertaining to coagulation factors and inhibitors, platelets and fibrin) and subsequent fibrinolysis.
The example thromboelastometry system 100 performs in vitro blood diagnostics, and is particularly advantageous at a point-of-care site (e.g., in a surgical theater while a patient is undergoing or preparing for surgery, or the like).
Additionally, the thromboelastometry system 100 can be used as a whole blood coagulation analysis system in a laboratory setting. The thromboelastometry system 100 provides a quantitative and qualitative indication of the coagulation state of a blood sample.
In some embodiments, a graphical presentation displayed on the graphical user interface 120 reflects the various blood diagnostic results (e.g., one or more plots, such as those sometimes refer to as a TEMogram, numeric data or measurements, or a combination thereof), which may describe the interaction between components like coagulation factors and inhibitors, fibrinogen, thrombocytes, and the fibrinolysis system. For example, referring also to FIG 2, in some embodiments the graphical user interface 120 provides a continuous graphic logging of the firmness of a blood clot during clot formation as a graphical presentation 200. FIG. 2 is an example of a graphic 200 that quantifies the firmness of a blood clot during clot formation, as calculated and displayed by the thromboelastometry system 100 during the performance of an assay, for example. In some embodiments, multiple such graphical presentations 200 pertaining to the firmness of a blood clot during clot formation are concurrently displayed on the graphical user interface 120.

Date Recue/Date Received 2020-06-30 Still referring to FIG. 1, in some embodiments the analyzer console 110 houses the hardware devices and sub-systems that control the operations of the thromboelastometry system 100. For example, the analyzer console 110 houses one or more processors and memory devices that can store an operating system and other executable instructions. In some embodiments, the executable instructions, when executed by the one or more processors, are configured to cause the system 100 to perform operations such as analyzing of the blood test result data indicative of the blood coagulation characteristics, and outputting via the user interface 120.
In some embodiments, the analyzer console 110 also houses various internal sub-systems, includes various electronic connection receptacles (not shown), and includes a cartridge port (not shown). The various electronic connection receptacles can include network and device connectors such as, but not limited to, one or more USB ports, Ethernet ports (e.g., RI45), VGA connectors, Sub-D9 connectors (RS232), and the like. Such connection receptacles can be located on the rear of the analyzer console 110, or at other convenient locations on the analyzer console 110. For example, in some embodiments one or more USB ports may be located on or near the front of the analyzer console 110. A USB port, so located, may provide user convenience for recording data onto a memory stick, for example. In some embodiments, the thromboelastometry system 100 is configured to operate using wireless communication modalities such as, but not limited to, Wi-Fi, Bluetooth, NFC, RF, IR, and the like.
Still referring to FIG. 1, in some embodiments, the graphical user interface is also used to convey graphical and/or textual user instructions to assist a user during the preparation of a blood sample for testing by the thromboelastometry system 100.
Optionally, the graphical user interface 120 is coupled to the analyzer console 110 and is a touchscreen display whereby the user can, for example, input information and make menu item selections. In some embodiments, the graphical user interface 120 is rigidly attached to the analyzer console 110. In particular embodiments, the graphical user interface 120 is pivotable and/or is otherwise positionally adjustable or removable in relation to the analyzer console 110.
The blood testing system 100 may also include a keyboard 130, and/or other types of user input devices such as a mouse, touchpad, trackball, and the like. In some embodiments, the thromboelastometry system 100 also includes an external

9 Date Recue/Date Received 2020-06-30 barcode reader. Such an external barcode reader can facilitate convenient one-dimensional or two-dimensional barcode entry of data such as, but not limited to, blood sample data, user identification, patient identification, normal values, and the like. Alternatively or additionally, the thromboelastometry system 100 can be equipped with a reader configured to read near-field communication tags, RFID
tags, or the like. In some embodiments, a computer data network (e.g., intranet, internet, LAN, etc.) may be used to allow for remote devices to receive and/or input information from the thromboelastometry system 100.
The depicted thromboelastometry system 100 also includes an electronic system pipette 160. Using the system pipette 160, a user can conveniently dispense volumetrically measured amounts of liquids (such as blood or reagents) during the process of preparing a blood sample prior to testing. In some embodiments, the system pipette 160 is a semi-automatic, software controlled device. For example, in some embodiments the system pipette 160 automatically extracts a targeted amount of liquid from one container, and then the user can dispense the targeted amount of liquid into another container.
In some embodiments, operation of the blood testing system 100 includes the use one or more reagents 170 that are mixed with a blood sample prior to performance of thromboelastometry. For example, the reagents 170 can comprise compounds such as, but not limited to, CaCl2, ellagic acid/phospholipids, tissue factor, heparinase, polybrene, cytochalasin D, tranexamic acid, and the like, and combinations thereof.
In some embodiments, the thromboelastometry system 100 will provide user instructions (e.g., via the graphical user interface 120) to mix particular reagents 170 with the blood sample using the system pipette 160.
The thromboelastometry analyzer console 110 also includes one or more individual thromboelastometry measurement stations 180 (which may also be referred herein to as "channels" or "measurement modules"). The depicted embodiment of thromboelastometry system 100 includes four individual thromboelastometry measurement stations 180 (i.e., four channels or four measurement modules).
As described further below, each thromboelastometry measurement station 180 includes a cup holder into which a user places a sample cup containing blood and reagents in preparation for thromboelastometry testing. In some embodiments, the Date Recue/Date Received 2020-06-30 cup holders are equipped with a heating system so that the samples can be warmed to and held approximately at body temperature (e.g., 37 +/- 1.0 C).
As described further below, in some embodiments each thromboelastometry measurement station 180 includes a pin or probe that can be removably positioned within the cup containing the sample to be tested. A clearance space exists between the probe and cup. In some embodiments, the shaft and probe is oscillated or otherwise rotated, back and forth, by about less than 10 (in both rotational directions), and preferably about 3 to about 6 (in both rotational directions). In some embodiments, such oscillations of the shaft and probe can be equal in magnitude in both rotational directions. The oscillations are measured, and as the blood/reagent mixture begins to become firmer because of thrombolysis, the oscillations are reduced. The measurements, by the thromboelastometry measurement station 180, of such oscillations over a period of time thereby generates thromboelastometry results.
Referring also to FIG. 3, an example rotary thromboelastometry actuation and detection system 300 that can be present in each thromboelastometry measurement station 180 (measurement module) is schematically depicted. In some implementations, a shaft 310 of the actuation and detection system 300 can engage with a single-use probe 138 to perform rotary thromboelastometry on a blood sample contained in a single-use cup 136. In FIG 3, the probe 138 and the cup 136 are shown in longitudinal cross-sections to allow for enhanced visibility and understanding of the example rotary thromboelastometry actuation and detection system 300 as a whole. In some embodiments, the probe 138 has an outer diameter of about 6 mm, and the cup 136 has an inner diameter of about 8 mm. However, the dimensions of the cup 136 and the probe 138 can be made suitably larger or smaller.
In this particular embodiment, the schematically depicted example rotary thromboelastometry actuation and detection system 300 includes a baseplate 302, a shaft 310, a bearing 312, a mirror 314, a counterforce spring wire 320, a light source 330, and a detector 340 (e.g., a charge-coupled device (CCD) or the like). The single-use cup 136 can be raised (e.g., by a user), as represented by arrows 318, such that a tip portion of the shaft 310 enters the bore 139 of the probe 138 to become releasably coupled with the probe 138. The bearing 312 is engaged with the baseplate 302 and the shaft 310 to facilitate rotational movement of the shaft 310 in relation to the baseplate 302. The spring wire 320 is coupled to the shaft 310 and an induced motion Date Recue/Date Received 2020-06-30 of the spring wire 320 (as driven by a motor described further below) can induce the shaft 310 to oscillate back and forth by less than 100 (in both rotational directions), and preferably about 30 to about 6 (in both rotational directions) as represented by arrow 316. The mirror 314 is coupled to the shaft 310. The light source 330 is configured to project light towards the mirror 314, and light can be reflected from the mirror 314 towards the detector 340 (in a direction that is dependent on the rotational orientation of the shaft 310). Accordingly, the motion of the probe 138 is detected by an optical detection system (e.g., the detector 340). It should be understood that other configurations of the rotary thromboelastometry actuation and detection system are also envisioned within the scope of this disclosure.
As the blood in the cup 136 begins to coagulate, the motion amplitude of the shaft 310 starts to decrease (as detected by the reflection of the light beam from mirror 314 towards the detector 340). During coagulation, the blood's fibrin backbone (together with platelets) creates a mechanical elastic linkage between the surfaces of the cup 136 and the probe 138. A proceeding coagulation process induced by adding one or more of the aforementioned activating factors (e.g., reagents) can thus be observed and quantified.
The detected motion data from the detector 340 is analyzed by an algorithm running on the analyzer console 110 to process and determine the thromboelastometry results. This system facilitates various thromboelastometiy parameters such as, but not limited to, clotting time, clot formation time, alpha angle, amplitude, maximum clot firmness, lysis onset time, lysis time, lysis index (%), and maximum lysis (%). In this way, various deficiencies of a patient's hemostatic status can be revealed and can be interpreted for proper medical intervention. At the end of the test process, the cup 136 can be lowered to uncouple the shaft 310 from the probe 138.
Still referring to FIG. 1, the analyzer console 110 can house one or more rotary thromboelastometry actuation and detection modules (AD-modules) 400 corresponding (e.g., one-to-one) with the one or more individual thromboelastometry measurement stations 180. Such rotary thromboelastometry AD-modules 400 can operate, for example, like the example rotary thromboelastometry actuation and detection system 300 described above in reference to FIG 3.
Referring to FIG. 4, an individual rotary thromboelastometry AD-module 400, broadly speaking, can include a housing 410 and a shaft 420. The shaft 420 can be Date Recue/Date Received 2020-06-30 configured to releasably couple with a single-use probe (e.g., probe 138 of FIG. 3) for the performance of thromboelastometry and/or thromboelastography as described above. That is, the shaft 420 can be rotationally oscillated back and forth, for example by less than 100 (in both rotational directions), and preferably about 3 to about 60 (in both rotational directions) as described above.
Referring also to FIG. 5, an exploded view of the rotary thromboelastometry AD-module 400 provides a greater visibility of the primary components of the AD-module 400. For example, the rotary thromboelastometry AD-module 400 includes the housing 410 (including three housing portions 410a, 410b, and 410c), the shaft 420, an actuation unit 430, a spring wire 440, an LED 450, a CCD 460, and a printed circuit board (PCB) assembly 470.
In some embodiments, the housing 410 includes a cover 410a, a base plate 410b, and a back-cover 410c. The housing 410 contains the other components of the AD-module 400, except for a portion of the shaft 420 which protrudes beyond the base plate 410b so that the shaft 420 can engage with a single-use probe.
Accordingly, in some embodiments the AD-module 400 is a discrete module that can be removed and replaced as a unit.
The rotary thromboelastometry AD-module 400 also includes the shaft 420.
In the depicted embodiment, the shaft 420 includes a bearing 422 and a mirror 424.
When the AD-module 400 is assembled, the bearing 422 is rigidly coupled with the base plate 410b. Hence, the shaft 420 can freely rotate in relation to the base plate 410b. The mirror 424, which is affixed to the shaft 420, is configured to reflect light from the LED 450 towards the CCD 460. As the shaft 420 oscillates during rotary thromboelastometry testing, the direction of the mirror 424 also oscillates correspondingly (because the mirror 424 is affixed to the shaft 420).
Therefore, during rotary thromboelastometry testing, light from the LED 450 will be reflected off of the mirror 424 (and towards the CCD 460) at changing angles as the shaft oscillates.
The rotary thromboelastometry AD-module 400 also includes the actuation unit 430. The actuation unit 430 (which will be described in more detail in reference to FIG. 6 below) provides the motive force that causes the shaft 420 to rotationally oscillate.

Date Recue/Date Received 2020-06-30 In the depicted embodiment, a spring wire 440 provides the linkage between the actuation unit 430 and the shaft 420. In other words, the actuation unit 430 drives the spring wire 440, and the spring wire 440 transmits the driving force from the actuation unit 430 to the shaft 420.
The rotary thromboelastometry AD-module 400 also includes the LED 450.
In some embodiments, the LED 450 is rigidly mounted to the PCB assembly 470, and the PCB assembly is rigidly mounted to the housing 410. The LED 450 emits light that is steadily directed toward the mirror 424. In some embodiments, one or more lenses are used in conjunction with the LED 450.
Light from the LED 450 reflects off of the mirror 424 in the direction of the CCD 460. The CCD 460 includes multiple pixels that are arranged along the face of the CCD 460 (e.g., arranged generally linearly). Accordingly, the light reflected from the mirror 424 scans across the face of the CCD 460 as the shaft 420 pivots.
By detecting the positions of the particular pixels of the CCD 460 that receive the LED
light, the angular position and other characteristics pertaining to the angular rotation of the shaft 420 can be determined. In some embodiments, other types of light detectors (other than a CCD type of detector) are used instead of, or in addition to the CCD 460.
The rotary thromboelastometry AD-module 400 also includes the PCB
assembly 470. The PCB assembly 470 includes electronic devices and circuitry that are used for the operation of the rotary thromboelastometry AD-module 400. In particular embodiments, the PCB assembly 470 (including executable code stored therein) comprises an evaluation unit configured for receiving brightness distribution data from the CCD, generating CCD calibration data based on the brightness distribution data, and comparing the CCD calibration data to real-time-measured CCD
calibration data. In some embodiments, the PCB assembly 470 includes a microprocessor, motor driver, fuses, integrated circuits, and the like. The PCB
assembly 470 can also include one or more types of sensors such as, but not limited to, vibration sensors, accelerometers, Hall-effect sensors, end-of-travel detectors, proximity sensors, optical sensors, micro-switches, and the like.
Referring to FIG. 6, an example actuation unit 430 of the rotary thromboelastometry AD-module 400 is shown in an exploded perspective view for greater visibility of the actuation unit's components. In the depicted embodiment, the Date Recue/Date Received 2020-06-30 actuation unit 430 includes a motor 432, a slider unit 434, and a slider guidance member 438. The motor 432 is mounted to the slider guidance member 438. The slider unit 434 is slidably engaged with the slider guidance member 438. The motor 432 is engaged with the slider unit 434 so that the motor 432 can provide a motive force to the slider unit 434, as described further below.
The example actuation unit 430 is designed so as to provide a number of operational advantages. For example, as will become more evident from the description below, the actuation unit 430 is compact, lightweight, resistant to external vibrations, mechanically precise, electronically instrumented, highly controllable, repeatably positionable, durable, and so on.
In some embodiments, the motor 432 is a stepper motor. Accordingly, in some such embodiments the motor 432 can be programmed and controlled to rotate and operate in a prescribed fashion. That is, in some embodiments the motor 432 can be programmed to operate in accord with selected parameters¨including parameters such as, but not limited to, rotational speed, number of revolutions, acceleration, deceleration, direction, and the like. Such factors can be programmed into the memory of the rotary thromboelastometry AD-module 400 or the analyzer console 110. Therefore, various actuation curves for the motor 432 can be readily selected and/or adjusted as desired. In some implementations, all rotary thromboelastometry AD-modules 400 are programmed to operate using the same actuation curve. In other implementations, one or more rotary thromboelastometry AD-module 400 are programmed to operate using a different actuation curve in comparison to one or more other rotary thromboelastometry AD-modules 400.
The motor 432 includes a drive shaft 433. In some embodiments, the drive shaft 433 is a lead screw. The external threads of the lead screw can be threadably engaged with an internally-threaded portion of the slider unit 434. In some such embodiments, the drive shaft 433 is finely-threaded lead screw to facilitate precise and smooth control of the slider unit 434. When the drive shaft 433 and the slider unit 434 are threadably engaged, a rotation of the motor 432 will result in a linear translation of the slider unit 434. That is, as the drive shaft 433 of the motor 432 rotates, the slider unit 434 will slidably translate within the slider guidance member 438. When the motor 432 reverses its direction of rotation (e.g., clockwise versus Date Recue/Date Received 2020-06-30 counter-clockwise), the linear direction of the slider unit 434 in relation to the slider guidance member 438 will be reversed correspondingly.
Referring also to FIG 7, an example of the slider unit 434 is shown in an exploded perspective view for greater visibility of the slider unit's components. The slider unit 434 includes a curved member 435, a threaded collar 436, a spring wire retention magnet 437, a slider unit retention magnet 439, a spring wire attachment member 452, and a slider body 454. The threaded collar 436 and the curved member 435 are affixed to the slider body 454. The spring wire retention magnet 437 is affixed to the curved member 435. The spring wire attachment member 452 is engaged with the curved member 435 and the slider body 454. The slider unit retention magnet 439 is affixed to the slider guidance member 438 and magnetically couples with the slider body 454.
The curved member 435 has a contoured lateral face with which the spring wire 440 (refer to FIG. 5) makes contact. As the curved member 435 linearly translates back and forth within the slider guidance member 438, the contact area between the spring wire 440 and the contoured lateral face of the curved member 435 positionally adjusts. That arrangement converts the linear motion of the curved member 435 into a smooth pivoting motion of the spring wire 440 (with the shaft 420 acting as the pivot point).
The spring wire retention magnet 437 attracts the spring wire 440 so that the spring wire 440 remains in contact with the contoured lateral face of the curved member 435 while the back and forth motion of the slider unit 434 takes place.

Additionally, in some embodiments the spring wire retention magnet 437 is used in conjunction with a Hall effect sensor mounted on the PCB assembly 470 (refer to FIG.
5) so that the position of the slider unit 434 can be electronically monitored.
The threaded collar 436 has internal threads that are complementary with the external threads of the drive shaft 433 of the motor 432. Accordingly, the threaded collar 436, being constrained from rotating because of engagement with the slider body 454, linearly translates along the length of the drive shaft 433 of the motor 432 as the drive shaft 433 turns. As the threaded collar 436 linearly translates, the slider body 454 and the curved member 435 also linearly translate (because the threaded collar 436 is affixed to the slider body 454). The slider unit retention magnet 439, being affixed to the slider guidance member 438 and magnetically coupled with the Date Recue/Date Received 2020-06-30 slider body 454, serves to precisely maintain the slider body 454 in a close running relationship with the slider guidance member 438 as the slider body 454 translates back and forth in relation to the slider guidance member 438.
The spring wire attachment member 452, which is coupled with the slider body 454, serves to mechanically engage the spring wire 440 (refer to FIG. 5) with the slider unit 434. The spring wire attachment member 452 thereby facilitates a mechanical connection between the spring wire 440 and the slider unit 434 (in addition to the aforementioned magnetic coupling between the spring wire 440 and the spring wire retention magnet 437). Moreover, in some embodiments the spring wire attachment member 452 includes physical features that are used for travel or end-of-travel detection of the slider unit 434. For example, in some embodiments the spring wire attachment member 452 includes one or more projections that are detectable by sensor(s) mounted on the PCB assembly 470. Photo-sensors, proximity sensors, mechanical sensors, and the like, can be used to detect the position of the spring wire attachment member 452 in that fashion.
Referring to FIG. 8, in some embodiments one or more processors of the thromboelastometry system 100 (refer to FIG. 1) is configured to perform a CCD

evaluation process 800. In particular embodiments, such a CCD evaluation process 800 can be implemented in one or more processors of an individual AD-module (e.g., in one or more processors of PCB assembly 470 of example AD-module 400; refer to FIGS. 4 and 5). In some such embodiments, each individual measurement module of a thromboelastometry system 100 can include one or more processors that are configured to perform the CCD evaluation process 800. Using the CCD evaluation process 800, thromboelastometry measurement inaccuracies can be reduced or eliminated in some cases. In result, the consistency of the performance (e.g., precision and accuracy) of the thromboelastometiy system 100 can be enhanced.
At step 810, one or more processors of the thromboelastometry system or AD-module receives CCD brightness distribution data. In some embodiments, multiple pixels of the CCD of an AD-module are activated using a light source (e.g., of the example AD-module 400; refer to FIG. 5). The resulting data generated by the multiple pixels is received by the one or more processors.
At step 820, the one or more processors of the thromboelastometry system or AD-module generates CCD calibration data using the CCD brightness distribution Date Recue/Date Received 2020-06-30 data received in step 810. In some embodiments, this is performed by making an evaluation of the position of a falling or rising edge of the brightness distribution data from the CCD. The falling or rising edge of the brightness distribution data may also be referred to herein as a "flank."
At step 830, the one or more processors of the thromboelastometry system or AD-module compare the calibration data generated in step 820 to real-time-measured CCD brightness data. In some embodiments, the real-time CCD evaluation process of step 830 is run (cycled) repeatedly while the thromboelastometry system is in operation. For example, in some embodiments the cycle time of the ongoing real-CCD evaluation process 830 is less than about every 200 milliseconds. In some embodiments, the ongoing real-time CCD evaluation process 830 is an optimization process to fit the samples from calibration to the currently measured position of a falling or rising edge of the brightness distribution data (or brightness distribution flank).
Referring to FIG. 9, in some embodiments one or more processors of the thromboelastomety system 100 (refer to FIG. 1) or AD-module is configured to perform a two-phase CCD evaluation process 900. The two-phase CCD evaluation process 900 includes a startup CCD evaluation process 910 and an ongoing real-time CCD evaluation process 920. Using the two-phase CCD evaluation process 900, thromboelastometry measurement inaccuracies can be reduced or eliminated in some cases. In result, the consistency of the performance (e.g., precision and accuracy) of the individual AD-modules and of the thromboelastometry system 100 as a whole can be enhanced.
In some embodiments, the first stage of the two-phase CCD evaluation process 900 is to generate calibration data in form of samples (data points) to fit on. This is done, starting at step 911, by making an evaluation of the best possible brightness distribution flank at startup of the thromboelastometry system 100. At each test position on the CCD, each light signal distribution is analyzed to decide whether the pixel is OK or not OK. As an example, some pixels of the CCD may be deemed to be not OK due to performance deficiencies caused by contamination on the CCD.
In some embodiments, the condition of the CCD pixels are analyzed by running a moving binomial average over the whole light distribution curve and comparing the resulting values to the measured data. For each pixel, if the difference Date Recue/Date Received 2020-06-30 between the moving binomial average over the whole distribution curve and the pixel's measured value is greater than a threshold value, in some embodiments the pixel is deemed to be not OK. Conversely, if the difference between the moving binomial average over the whole distribution curve and the pixel's measured value is less than a threshold value, the pixel is deemed to be OK.
In step 912, data regarding each pixel is stored in a buffer. That is, because the whole CCD is analyzed in step 911, a map of the disrupted pixels can be calculated by storing the position of all disrupted pixels in a buffer. The data is also used as an input to the ongoing real-time CCD evaluation process 920.
In step 913, the position of the CCD with the least concentration of not OK
pixels is determined as the best position to calibrate the CCD evaluation algorithm at.
The mirror on the shaft (refer to FIG 4) is then rotationally positioned so that the LED
light reflecting from the mirror is directed to the best position on the CCD.
In step 914, the measured brightness distribution curve at the best position is then filtered to remove outlier errors of the measured brightness distribution curve at the best position. In some embodiments, a filtering process is applied to linearly approximate outlier parts of the brightness distribution curve. This stage is configured to resolve problems caused, for example, by any dirt that shades parts of the CCD. These dirty parts are mostly noticeable as wide and distinct areas of significantly less illumination than usual (outlier errors). In some embodiments, this step uses an algorithm that includes two stages. The first stage is to sample the curve using a fixed step width and looking for unnatural outliers to be corrected.
The second stage takes the start point of the outlier and searches for the end of the outlier.
It does so by approximating a slope of the brightness distribution curve. The algorithm assumes that the closest OK point is in the area of the extended line of this slope. Looking at the shape of a typical CCD brightness distribution curve and the resulting errors from dirt on the CCD, outliers should only increase point values. This algorithm has a low memory footprint and runs fast in comparison to some more complicated filter kernels and FFT approaches.
In step 915, from the filtered data of step 914, a part of the right falling or rising edge of the brightness distribution data (flank) is extracted. The algorithm is designed to perform a robust detection of the right edge of the outlier filtered brightness distribution given.

Date Recue/Date Received 2020-06-30 In some embodiments, starting from the minimum, the search algorithm is designed to find the latest possible occurrence of a good match to the searched value.
Because the brightness distribution data curve is rising, the latest possible occurrence has a high probability of being the wanted position. This custom made algorithm is very fast and reliable with low memory footprint.
In step 916, the extracted brightness distribution flank is then smoothed and sampled. In some embodiments, this is done by applying very little noise to the flank and approximating the result with a curve fit model. Cubic B-splines with sufficient interpolation points can approximate a nonlinear curve very well and hence are superior to typical polynomial or linear interpolation that show only good performance if the curve has the right shape.
In steps 917 and 918, samples with fixed step width are extracted as the final calibration step and stored in a buffer. This substantially reduces the memory footprint and speeds up the real-time evaluation, since less comparison operations need to be done.
The startup CCD evaluation process 910 is complete once the buffer containing the positions of the not OK pixels (step 912) and the buffer containing the samples for the real time light beam position evaluation (step 918) are appropriately populated.
The ongoing real-time CCD evaluation process 920 is run (cycled) repeatedly while the thromboelastometry system 100 is in operation. For example, in some embodiments the cycle time of the ongoing real-time CCD evaluation process 920 is about every 50 milliseconds. The ongoing real-time CCD evaluation process 920 is an optimization process to fit the samples from calibration to the currently measured brightness distribution flank.
In step 921, the samples from step 918 are fit in comparison to a target position by an interval based algorithm. The algorithm evaluates the samples in the middle of an interval, which contains the possible target positions on the left side. In some embodiments, the first interval (space) is the whole CCD pixel range. The algorithm then decides if the wanted position is on right or left side of the desired position (which is possible because the brightness distribution is monotone).
That is, if any pixel to the right of the middle is bigger, a new right border is determined. The current evaluated position now acts as the new right or left border of the new interval Date Recue/Date Received 2020-06-30 which halves the searched CCD pixel range. This scheme is repeatedly executed until the interval (space) has a length of one which means the destination is reached. This first fast fit algorithm greatly reduces the overall time needed to fit the samples to the measured curve. The algorithm only needs about 10 iterations to find the target position within about 10 pixel accuracy. The algorithm is superior in terms of speed in comparison to the more common least average approach used after this fast fit.
In step 922, a precise weighted convergence to fit the samples as good as possible is performed. This is done by calculating the average of the absolute distances between all samples and their counterparts in the brightness distribution curve. Since for every pixel, information about their status (OK or not OK) is in the memory, one can ignore samples that compare to not OK pixels. This greatly enhances robustness in comparison to a typical approach without ignoring known bad pixels.
In step 923, the location of the samples on the X-Axis (CCD Pixel Position, buffer position) of the light beam position is determined and sent to software.
Referring to FIG. 10, an AD-module error detection process 1000 is a loop process that can be performed by a processor of a thromboelastometry measurement system. The AD-module error detection process 1000 can be performed to evaluate parameters that may be indicative of thromboelastometry actuation and detection system error causes.
At step 1010, the AD-module error detection process 1000 begins. The AD-module error detection process 1000 can be performed in parallel with a thromboelastometry measurement process.
At step 1020, a processor of the thromboelastometry measurement system receives data that pertains to a detected amount of vibration that may affect the accuracy or precision of thromboelastometry measurement data from an AD-module.
In some embodiments, the vibration is measured via a ball-based sensor that is a component of the AD-module (e.g., located on a PCB within the AD-module housing). In some embodiments, other types of sensors are used for vibration detection, such as one or more accelerometers, piezoelectric sensors, displacement sensors, velocity sensors, and the like.

Date Recue/Date Received 2020-06-30 At step 1030, the processor compares the received vibration data to one or more threshold values. If the received vibration data is greater than the threshold values, the processor generates a vibration-related error indication in step 1040.
At step 1050, a processor of the thromboelastometry measurement system receives data that pertains to a detected position of moving components of an AD-module that may affect the accuracy or precision of thromboelastometry measurement data from the AD-module. For example, the positional indication data may include, but is not limited to, end-of-travel data, rotational position data, linear translation position data, and the like, and combinations thereof. In some embodiments, an end-of-travel switch that is a component of the AD-module (e.g., located on a PCB
within the AD-module housing) is used to detect the absolute position of the AD-module actuation unit. In some embodiments, the end-of-travel switch is in form of a photo optic sensor, or a proximity sensor, limit switch, and the like. In some embodiments, a Hall effect sensor that is a component of the AD-module (e.g., located on a PCB
within the AD-module housing) is used to generate positional indication data.
Other types of sensors that provide positional indication data may also be utilized.
At step 1060, the processor compares the received data that pertains to a detected position of moving components of an AD-module to one or more threshold values. If the received positional data is greater than the threshold values, the processor generates a position error indication in step 1070. The process 1000 loops back to step 1020 and repeats the process 1000.
Referring to FIG. 11, a process flowchart describes an AD-module measurement loop 1100 and a thromboelastometry measurement and evaluation loop 1150 in substantial detail. The processes 1100 and 1150 include steps for supervising the operations of a thromboelastometry system 100 (refer to FIG. 1) to enhance error detection and the accuracy of the thromboelastometry system.
During thromboelastometry measurement, key aspects are supervised and evaluated in real-time using processes 1100 and 1150. For example, vibrations that might distort the measurement signal are supervised and evaluated. Also, the movement quality of the rotary thromboelastometry actuation and detection system is supervised and evaluated with a Hall effect sensor. In addition, the movement precision of the rotary thromboelastometry actuation and detection system is supervised and evaluated using one or more end-of-travel sensors. Further, the Date Recue/Date Received 2020-06-30 quality of the measurement signal is evaluated. The vibration, movement quality, and movement precision, in combination with the light beam position, allow the processor of the thromboelastometry system to determine the current quality of the measurement signal, analyze the cause of distortions, and take responsive measures.
In some embodiments, the AD-module measurement loop 1100 is executed about every 50 milliseconds. In particular embodiments, the AD-module measurement loop 1100 is part of the normal measurement routine on the AD-module.
Steps 1104 and 1106 pertain to the position of the LED light beam of the AD-module. For example, in some embodiments the light beam position is detected and evaluated.
Steps 1108 to 1114 pertain to the evaluation of the vibration. In some embodiments, the vibration is measured via a ball-based sensor that is a component of the AD-module (e.g., located on a PCB within the AD-module housing). In some embodiments, other types of sensors are used for vibration detection, such as one or more accelerometers, piezoelectric sensors, displacement sensors, velocity sensors, and the like. The resulting data that needs to be evaluated are vibration events over time. A typical evaluation algorithm could be a limit only allowing a certain amount of vibration events over a certain amount of time. If the limit is exceeded, an error message is sent to the processor running the thromboelastometry measurement software.
Steps 1116 to 1120 include the evaluation of the rotary thromboelastometry actuation and detection system by supervision with a Hall effect sensor that is a component of the AD-module (e.g., located on a PCB within the AD-module housing). The measured data provides a characterization of the actual movement of the system. In some embodiments, an evaluation algorithm could be run to compare the measured movement with the theoretical movement the rotary thromboelastometry actuation and detection system should execute. For example, a sum of absolute/squared difference between theory and reality are suitable algorithms when optimized properly. If a threshold amount of differences are detected, an error message is sent to the processor running the thromboelastometry measurement software (at step 1122).
Steps 1124 and 1126 include the evaluation of the absolute movement position of the rotary thromboelastometry actuation and detection system. An end switch that Date Recue/Date Received 2020-06-30 is a component of the AD-module (e.g., located on a PCB within the AD-module housing) is used to detect the absolute position of the actuation unit with sub step (stepper motor) precision. In some embodiments, the end switch is in form of a photo optic sensor, or a proximity sensor, limit switch, and the like. The gathered statistical data of the deviation from the optimal position is used to determine if the actuation is operating as expected. If the actual position is differing enough from the target position for a threshold amount of time, an error message is sent to the processor running the thromboelastometry measurement software (at step 1122).
At step 1122, the data gathered regarding the actuation quality from steps through 1126 allows a complete evaluation of the motion quality of the rotary thromboelastometry actuation and detection system. In some embodiments, the evaluation is attainable at low cost and small space in comparison, for example, to using an extra encoder for monitoring the stepper motor.
Turning now to a description of the thromboelastometry measurement and evaluation loop 1150. Steps 1154 through 1158 pertain to the thromboelastometry measurement process as performed by the processor running the thromboelastometry measurement software.
Steps 1160 and 1162 describe the evaluation of the errors sent by the AD-module from process 1100. After the position is evaluated, the additional errors sent by the AD-module can be used to interpret the currently known errors by the processor running the thromboelastometry measurement software. The error type and frequency are evaluated by the software, and error messages are shown to the user if they are significant enough in frequency or if they are critical enough. In some embodiments, the AD-module errors can be correlated to measurement errors by the processor running the thromboelastometry measurement software, delivering additional information on what caused the errors and assisting further improvements on hardware, electronics, and firmware.
A number of embodiments of the invention have been described.
Nevertheless, it will be understood that various modifications may be made without departing from the scope of the invention.

Date Recue/Date Received 2020-06-30

Claims (7)

WHAT IS CLAIMED IS:

1. A method for evaluating a charge-coupled device (CCD) component of a thromboelastometry analysis system, the method cornprising:
receiving, at one or more processors of the thromboelastometry analysis system, brightness distribution data from the CCD, wherein the brightness distribution data from the CCD represents individual brightness data from a plurality of individual pixels of the CCD;
generating, by the one or rnore processors of the thromboelastometry analysis system, CCD
calibration data, wherein the CCD calibration data is generated based on the brightness distribution data from the CCD; and comparing, by the one or rnore processors of the thromboelastometry analysis system and while the thromboelastometry analysis system is performing a thromboelastometry analysis, the CCD calibration data to real-time-measured CCD brightness distribution data.

2. The method of claim 1, further comprising determining, by the one or more processors of the thromboelastometry analysis system, a position of a falling or rising edge of the brightness distribution data from the CCD.

3. A method of controlling accuracy of a thromboelastometry analysis system, the method cornprising:
receiving, at one or rnore processors of the thromboelastometry analysis systern, vibration data indicative of a detected level of vibration of the thrornboelastometry analysis system;
comparing, by the one or rnore processors of the thromboelastometry analysis system, the received vibration data to a threshold limit value; and generating, by the one or more processors of the thromboelastometry analysis system and based on the cornparison of the received vibration data to the threshold limit value, a vibration error indication in response to the received vibration data being greater than the threshold limit value.

4. The method of claim 3, further comprising:
Date Recue/Date Received 2020-06-30 receiving, at one or more processors of the thromboelastometry analysis system, positional indication data indicative of a detected position of a slider unit in relation to a actuation unit of the thromboelastometry analysis system;
cornparing, by the one or more processors of the thromboelastometry analysis system, the received positional indication data to one or more threshold limit values; and generating, by the one or more processors of the thromboelastometry analysis system and based on the comparison of the received positional indication data to the one or more threshold limit values, a position error indication in response to the received positional indication data being greater than the one or more threshold limit values.

5. A method of controlling accuracy of a thromboelastometry analysis system, the rnethod comprising:
receiving, at one or more processors of the thromboelastometry analysis system, positional indication data indicative of a detected position of a slider unit in relation to a actuation unit of the thromboelastometry analysis system;
comparing, by the one or more processors of the thromboelastometry analysis system, the received positional indication data to one or more threshold limit values; and generating, by the one or more processors of the thromboelastometry analysis system and based on the comparison of the received positional indication data to the one or more threshold limit values, a position error indication in response to the received positional indication data being greater than the one or more threshold limit values.

6. The method of clairn 5, wherein the positional indication data comprises one or more signals from one or more end-of-travel sensors that indicate whether the slider unit is positioned at a targeted travel limit position.

7. The method of clairn 5 or 6, wherein the positional indication data comprises one or more signals from one or more sensors that indicate a real-time position of the slider unit as the slider unit linearly translates back and forth along a linear path.

Date Recue/Date Received 2020-06-30